Log In
Print
BCIQ
Print
Print this Print this
 

RUT58-60

  Manage Alerts
Collapse Summary General Information
Company Ruthigen Inc.
DescriptionBroad-spectrum anti-infective stable formulation of hypochlorous acid
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard Indication Infectious (unspecified)
Indication DetailsAdjunct therapy to systemic antibiotics to prevent infections associated with abdominal surgery; Prevent and treat infection in trauma and surgical procedures
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

$8.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today